homemarket NewsStocks To Watch: LIC, RailTel, RVNL, Amber Enterprises, Torrent Power and more

Stocks To Watch: LIC, RailTel, RVNL, Amber Enterprises, Torrent Power and more

Multiple Rail, Defence and Power PSUs will be in focus today due to their respective order wins.

Profile image

By CNBCTV18.com Mar 18, 2024 5:22:59 AM IST (Published)

Listen to the Article(6 Minutes)
2 Min Read
Stocks To Watch: LIC, RailTel, RVNL, Amber Enterprises, Torrent Power and more
LIC |

Share Market Live

View All
In confirmation of a CNBC-TV18 newsbreak, the government confirmed the wage hike of LIC employees. The government has approved a 17% wage hike of LIC Employees, which will benefit more than 1.1 lakh LIC employees and over 30,000 pensioners.

Railtel RailTel | Wins order worth ₹352 crore from the BMC for supply, operations and maintenance of HMIS, which is the health department of the municipal body. It has also won a ₹130 crore order in Bihar.
Aditya Birla Fashion | Gets no objection letter from BSE, NSE on scheme of merger of company with TCNS Clothing. Effectiveness of the scheme will be subject approval of the NCLT & other necessary approvals.
Amber Enterprises | Incorporated a wholly-owned subsidiary called AT Railway Sub Systems Pvt. Ltd. to carryout the business of railway components and sub systems for the rolling stock industry in India and overseas and to expand their businesses into the global markets.
RVNL | Gets LoA for a project worth ₹339.2 crore from the Maharashtra Metro Rail Corporation.
IRCON | Gets an LoA for construction project worth ₹630 crore from NHIDCL
Hindustan Aeronautics | Gets ₹2,890 crore order from Defence Ministry from Mid Life upgrade of 25 Dornier Aircraft of Indian Navy.
torrent power Torrent Power | Gets Letter of Award for Setting up of 300 MW Wind Solar Hybrid Projects. The projects will have a tariff of ₹3.65 kWh and the contract period will be worth 25 years.
Aurobindo Pharma, Aurobindo Pharma share, Aurobindo Pharma subsidiary, Aurobindo Pharma cancer drug, Aurobindo Pharma CDSCO marketing authorisation Aurobindo Pharma | Arm CuraTeQ Biologics announces successful Phase 1 clinical study outcome of their BP 11 product, which is similar to Xolair
lupin, Avendus Spark Lupin | USFDA issues form 483 with one observation for its Aurangabad facility which was inspected between March 6 - 15, 2024.
SJVN | Gets Letter of Intent from Gujarat Urja Vikas Nigam Ltd. for a 200 MW solar project.

Most Read

Share Market Live

View All
Top GainersTop Losers
CurrencyCommodities
CurrencyPriceChange%Change